Total Visits

Views
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.46

Total Visits Per Month

May 2020June 2020July 2020August 2020September 2020October 2020November 2020
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.2013403

File Downloads

Views

Top country views

Views
United Kingdom21
United States21
Germany3
Japan1

Top cities views

Views
Ashburn10
Cambridge7
Fairfield4
Boardman2
Champaign2
Islington1
London1
Oakland1
Osaka1
Pinner1